卡紐替尼抑制劑Canertinib is a pan-erbB tyrosine kinase inhibitor which work against esophageal squamous cell carcinoma in vitro and in vivo. Canertinib treatment significantly affects tumour metabolism, proliferation and hypoxia as determined by PET.
產品名稱: | 卡紐替尼 | ||
英文名: | Canertinib | ||
CAS NO.: | 267243-28-7 | ||
分子式: | C23H23ClFN5O3 | ||
分子量: | 471.911827325821 | ||
產品品牌: | targetmol | ||
產品規格: | 5mg |